Concurrent Session 1: Adaptive Immunity and Autoimmunity

Date: Thursday 19 September 2019, 14.40-16.10
Room: Amphitheatre A

Chairs: TBA

Program

14.40-14.50 012 (Poster 028)
The activation status of nuclear factor κB in type 2 conventional dendritic cells before therapy correlates with clinical response to adalimumab
R Andres Ejarque, P Di Meglio and o PSORT Consortium King’s College London, London, United Kingdom 
14.50-15.00 013 (Poster 006)
Skin Dendritic Cells Progressively Subvert The Activation Of Pathogenic Type-2 Immunity Upon Epicutaneous Allergen Immunotherapy
L Laoubi,1,2 H Sampson,2 L Mondoulet,2 J Nicolas,1 V Dioszeghy2 and M Vocanson1 1CIRI – INSERM U1111, ENS de Lyon, UCBL1, CNRS UMR 5308, Lyon, France and 2DBV Technologies, Montrouge, France 
15.00-15.10 014 (Poster 017)
Tc2 induction of IL-10-producing plasmablasts during contact hypersensitivity
Y Matsumura,2 R Watanabe,2 H Koguchi-Yoshioka,2,S Vo1 and M Fujimoto1, 1Dermatology, Graduate school of Medicine, Osaka University, Osaka, Japan and 2Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan 
15.10-15.20 015 (Poster 029)
The IL-31-producing circulating T cells subset represents a unique population of CLA+ CRTH2+ CCR4+ effector memory T cells
A Datsi,1 K Raba,3 S Kellermann,1 A van Lierop,1, P Olah,1,2 R Sorg3 and B Homey1, 1Department of Dermatology, University of Duesseldorf, Duesseldorf, Germany, 2Dermatology, University of Pécs, Pécs, Hungary and 3Institute of Transplantation Diagnostics and Cell Therapeutics, University of Duesseldorf, Duesseldorf, Germany 
15.20-15.30 016 (Poster 009)
Real-time in vivo imaging of CD8+ T cell-mediated keratinocyte apoptosis in a graft versus host disease-like murine model
H Cheng,1,2 T Honda,2 J Sakabe,3 Y Tokura3 and K Kabashima2 1National Skin Centre, Singapore, Singapore, 2Dermatology, Kyoto University, Kyoto, Japan and 3Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan 
15.30-15.40 017 (Poster 031)
Development of a mouse model of Pemphigus Vulgaris as a tool to evaluate nanoparticle induced antigen-specific tolerance
C Hudemann,1 R Pollmann,1 M Hertl,1 S Fleischer2 and R Eming1 1Department of Dermatology and Allergology, Philipps-University Marburg, Marburg, Germany and 2Topas Therapeutics GmbH, Hamburg, Germany 
15.40-15.50 018 (Poster 008)
PPARγ regulates IL-9 expression in human TH2 cells by promoting glycolysis
L von Meyenn,1 O Steck,1 O Friedli,2 N Bertschi,1 S Freigang2 and C Schlapbach1 1Department of Dermatology, Inselspital, Bern University Hospital, Bern, Switzerland and 2Institute of Pathology, University of Bern, Bern, Switzerland 
15.50-16.00 019 (Poster 022)
Crosstalk between vitiligo skin T-cell secretome and epidermal cell response
C Martins,1 C Drullion,1 L Migayron,1 C Jacquemin,1 F Lucchese,1 A Taieb,1,2 J Seneschal1,2 and K Boniface1 1University of Bordeaux, Bordeaux, France and 2Bordeaux Hospital, Bordeaux, France 
16.00-16.10  020 (Poster 024)
Downregulated expression of Interferon regulatory factor 8 in monocytes/macrophages exhibits pro-fibrotic phenotype and may contribute to the pathogenic process of systemic sclerosis
Y Ototake,1 Y Yamaguchi,1 M Asami,1 N Komitsu,1 T Watanabe,1 D Kurotaki,2 T Tamura2 and M Aihara1 1Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan and 2Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan